Literature DB >> 31644473

Adrenal tumours: open surgery versus minimally invasive surgery.

Cristian Fiori1, Enrico Checcucci, Daniele Amparore, Giovanni Cattaneo, Matteo Manfredi, Francesco Porpiglia.   

Abstract

PURPOSE OF REVIEW: The aim of this article is to focus on state-of-the-art minimally invasive adrenalectomy (MIA) and the most recent role of open adrenalectomy for adrenal tumours, respect to MIA and open adrenalectomy for adrenocortical cancer (ACC). RECENT
FINDINGS: The laparoscopic (both transperitoneal and retroperitoneal) approach is the first-choice treatment in cases of small-to-medium benign adrenal tumours. This approach is feasible and well tolerated even for larger lesions without radiological signs of malignancy. Robotic adrenalectomy has recently increased in popularity, although the results appear to be fully comparable with those of laparoscopy. Open approach is the keystone of ACC surgery, especially when neighbour tissues, organs, or vessels are involved. Recent evidence suggests caution in treating localized ACC with laparoscopy, because of the higher rate of local or peritoneal recurrence, and shorter recurrence-free survival rates with respect to open adrenalectomy.
SUMMARY: MIA has progressively replaced the traditional open approach and plays a complementary role in the treatment of adrenal tumour. It is the first option for benign lesions, whereas open adrenalectomy is a cornerstone treatment for ACC. The overlap of indications for laparoscopic adrenalectomy and open adrenalectomy is today confined to the treatment of organ-confined adrenal cancer, in which the role of laparoscopic surgery is far from being clearly defined.

Entities:  

Mesh:

Year:  2020        PMID: 31644473     DOI: 10.1097/CCO.0000000000000594

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  3 in total

1.  Retroperitoneal Laparoscopic Surgery in the Treatment of Complex Adrenal Tumors.

Authors:  Kai Huang; Yehua Wang; Xiao Gu; Qin Xiao; Xiangan Tu
Journal:  Cancer Manag Res       Date:  2020-07-14       Impact factor: 3.989

Review 2.  Management of adrenocortical carcinoma: are we making progress?

Authors:  Barbara Kiesewetter; Philipp Riss; Christian Scheuba; Peter Mazal; Elisabeth Kretschmer-Chott; Alexander Haug; Markus Raderer
Journal:  Ther Adv Med Oncol       Date:  2021-08-31       Impact factor: 5.485

Review 3.  Forecasting the Future of Urology Practice: A Comprehensive Review of the Recommendations by International and European Associations on Priority Procedures During the COVID-19 Pandemic.

Authors:  Daniele Amparore; Riccardo Campi; Enrico Checcucci; Francesco Sessa; Angela Pecoraro; Andrea Minervini; Cristian Fiori; Vincenzo Ficarra; Giacomo Novara; Sergio Serni; Francesco Porpiglia
Journal:  Eur Urol Focus       Date:  2020-05-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.